Paper2986291
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.
Barin F and 5 others. Science, 1985. Cited by 246 papers, by iCite.
Cite this record
ConductScience Library. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Papers, record 2986291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2986291
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| Antibodies, Viral | Major topic |
| Antigens, Viral | Major topic |
| Deltaretrovirus | Major topic |
| Viral Envelope Proteins | Major topic |
| Antibody Specificity | |
| Electrophoresis, Polyacrylamide Gel | |
| Humans | |
| Immunologic Techniques | |
| Molecular Weight |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 2T32-CA09031 | NCI NIH HHS | United States | T32CA009031 | PubMed and NIH | NIH RePORTER |
| CA 13885 | NCI NIH HHS | United States | R01CA013885 | PubMed and NIH | NIH RePORTER |
| CA 37466 | NCI NIH HHS | United States | U01CA037466 | PubMed and NIH | NIH RePORTER |
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 246 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39508605 | Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation. | J Virol | 2024 | https://conductscience.org/library/papers/39508605 | PubMed |
| 35335016 | Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35335016 | PubMed |
| 30115684 | Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake. | J Biol Chem | 2018 | https://conductscience.org/library/papers/30115684 | PubMed |
| 27802337 | Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China. | PLoS One | 2016 | https://conductscience.org/library/papers/27802337 | PubMed |
| 23903848 | Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120. | J Virol | 2013 | https://conductscience.org/library/papers/23903848 | PubMed |
| 22864288 | Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer. | Nat Struct Mol Biol | 2012 | https://conductscience.org/library/papers/22864288 | PubMed |
| 20980495 | The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter. | J Virol | 2011 | https://conductscience.org/library/papers/20980495 | PubMed |
| 20716359 | Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. | Retrovirology | 2010 | https://conductscience.org/library/papers/20716359 | PubMed |
| 20219932 | Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity. | J Virol | 2010 | https://conductscience.org/library/papers/20219932 | PubMed |
| 19763269 | Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. | PLoS Pathog | 2009 | https://conductscience.org/library/papers/19763269 | PubMed |
| 18768967 | Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response. | J Virol | 2008 | https://conductscience.org/library/papers/18768967 | PubMed |
| 18310320 | Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18310320 | PubMed |
| 17942537 | Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection. | J Virol | 2008 | https://conductscience.org/library/papers/17942537 | PubMed |
| 16145089 | Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16145089 | PubMed |
| 15016849 | N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies. | J Virol | 2004 | https://conductscience.org/library/papers/15016849 | PubMed |
| 14715727 | Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen. | J Clin Microbiol | 2004 | https://conductscience.org/library/papers/14715727 | PubMed |
| 10846104 | Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41. | J Virol | 2000 | https://conductscience.org/library/papers/10846104 | PubMed |
| 9817891 | Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2. | J Clin Microbiol | 1998 | https://conductscience.org/library/papers/9817891 | PubMed |
| 9114392 | Detection of human immunodeficiency virus type 1 (HIV-1) antibody by western blotting and HIV-1 DNA by PCR in patients with AIDS. | J Clin Microbiol | 1997 | https://conductscience.org/library/papers/9114392 | PubMed |
| 8548538 | Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus. | Clin Diagn Lab Immunol | 1995 | https://conductscience.org/library/papers/8548538 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| ENPEP | 2028 | PubTator's text mining | https://conductscience.org/library/genes/2028 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
| TMED2 | 10959 | PubTator's text mining | https://conductscience.org/library/genes/10959 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2986291
GET https://conductscience.org/api/papers/v1/2986291/cited_by?page=2